b 861 150 (Flecainide 150 mg)

Pill imprint b 861 150 has been identified as Flecainide acetate 150 mg.

Flecainide is used in the treatment of atrial fibrillation; atrial flutter; supraventricular tachycardia; paroxysmal supraventricular tachycardia; ventricular tachycardia (and more), and belongs to the drug class group I antiarrhythmics. Risk cannot be ruled out during pregnancy. Flecainide 150 mg is not a controlled substance under the Controlled Substance Act (CSA).

Flecainide acetate

Imprint:

b 861 150

Strength:

150 mg

Color:

White

Size:

14.00 mm

Shape:

Elliptical / Oval

Availability:

Prescription only

Drug Class:

Group I antiarrhythmics

Pregnancy Category:

C - Risk cannot be ruled out

CSA Schedule:

Not a controlled drug

Manufacturer:

Teva Pharmaceuticals USA

National Drug Code (NDC):

00555-0861

Inactive Ingredients:

silicon dioxide
croscarmellose sodium
magnesium stearate
microcrystalline cellulose
corn starch
sodium stearyl fumarate

More info Print Imprint Search

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.